ArticleCurrent microbiology2018
Streptomyces lasii sp. nov., a Novel Actinomycete with Antifungal Activity Isolated from the Head of an Ant (Lasius flavus).
Article in Current microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Multilevel variation in pathogen susceptibility and grooming behavior in ant societies.Die Naturwissenschaften · 2026Article
- Taxonomic descriptions of Nocardia anocheti sp. nov. and Streptomyces odontomachicola sp. nov. isolated from ants.Scientific reports · 2026Article
- Streptomyces odontomachi sp. nov., a novel actinobacterium with antimicrobial potential isolated from ants (Odontomachus simillimus Smith, 1858).The Journal of antibiotics · 2024Article
- Semi-arid's Unsung Heroes: Hymenoptera and the Vital Ecosystem Services Enabled by Encholirium spectabile, a Rupicolous Bromeliad in the Brazilian Semi-arid Region.Neotropical entomology · 2024Article
- Actinomycetes associated with hymenopteran insects: a promising source of bioactive natural products.Frontiers in microbiology · 2024Review
- Antibiotics from Insect-Associated Actinobacteria.Biology · 2022Review
- Bioinformatic comparison of three Embleya species and description of steffimycins production by Embleya sp. NF3.Applied microbiology and biotechnology · 2022Article
- Review
- Taxonomic Characterization and Secondary Metabolite Analysis of NEAU-wh3-1: AnMicroorganisms · 2020Article
- Community Composition, Antifungal Activity and Chemical Analyses of Ant-Derived Actinobacteria.Frontiers in microbiology · 2020Article
- A Human Lung-AssociatedFrontiers in microbiology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
During a screening for novel and biotechnologically useful actinobacteria in insects, a novel actinobacteria with antifungal activity, designated strain 5H-CA11
Indexed as
Identifiers
29119234What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.